dehydroepiandrosterone sulfate has been researched along with Myotonic Dystrophy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sugino, M | 1 |
| Ishida, S; Ito, T; Kimura, F; Ohsawa, N; Shinoda, K; Sugino, M; Yamasaki, H | 1 |
| Furutama, D; Ohsawa, N; Tagami, M; Tsuji, K | 1 |
1 trial(s) available for dehydroepiandrosterone sulfate and Myotonic Dystrophy
| Article | Year |
|---|---|
A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy.
Topics: Activities of Daily Living; Adult; Dehydroepiandrosterone Sulfate; Female; Humans; Male; Middle Aged; Myotonic Dystrophy; Pilot Projects | 1998 |
2 other study(ies) available for dehydroepiandrosterone sulfate and Myotonic Dystrophy
| Article | Year |
|---|---|
Dehydroepiandrosterone sulfate (DHEAS) therapy for myotonic dystrophy type 1 and myotonia.
Topics: Adult; Animals; Dehydroepiandrosterone Sulfate; Humans; Male; Mice; Myotonia; Myotonic Dystrophy; Rats; Treatment Outcome | 2005 |
Specific binding and effects of dehydroepiandrosterone sulfate (DHEA-S) on skeletal muscle cells: possible implication for DHEA-S replacement therapy in patients with myotonic dystrophy.
Topics: Animals; Binding, Competitive; Cell Division; Cell Line; Cell Nucleus; Cholesterol Esters; Dehydroepiandrosterone Sulfate; Gene Expression; Hormone Replacement Therapy; Humans; Insulin-Like Growth Factor I; Kinetics; Mice; Muscle, Skeletal; Myotonic Dystrophy; RNA, Messenger; Solubility; Steroids; Subcellular Fractions | 1999 |